CN104178556B - 神经胶质瘤分子分型基因群及其应用 - Google Patents
神经胶质瘤分子分型基因群及其应用 Download PDFInfo
- Publication number
- CN104178556B CN104178556B CN201310202569.1A CN201310202569A CN104178556B CN 104178556 B CN104178556 B CN 104178556B CN 201310202569 A CN201310202569 A CN 201310202569A CN 104178556 B CN104178556 B CN 104178556B
- Authority
- CN
- China
- Prior art keywords
- gene group
- expression amount
- average expression
- group average
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 172
- 206010018338 Glioma Diseases 0.000 title claims abstract description 114
- 208000032612 Glial tumor Diseases 0.000 title claims abstract description 79
- 101150014767 EM gene Proteins 0.000 claims abstract description 91
- 238000004393 prognosis Methods 0.000 claims abstract description 62
- 101001126417 Homo sapiens Platelet-derived growth factor receptor alpha Proteins 0.000 claims abstract description 8
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 8
- 102100030485 Platelet-derived growth factor receptor alpha Human genes 0.000 claims abstract description 8
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 claims abstract 3
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 claims abstract 3
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 claims abstract 3
- 230000014509 gene expression Effects 0.000 claims description 173
- 108020004999 messenger RNA Proteins 0.000 claims description 19
- 238000000338 in vitro Methods 0.000 claims description 13
- 238000012360 testing method Methods 0.000 claims description 12
- 239000003153 chemical reaction reagent Substances 0.000 claims description 10
- 238000009396 hybridization Methods 0.000 claims description 6
- 102100026026 Acyl-CoA synthetase short-chain family member 3, mitochondrial Human genes 0.000 claims description 4
- 102100036793 Adhesion G protein-coupled receptor L3 Human genes 0.000 claims description 4
- 102100025985 BMP/retinoic acid-inducible neural-specific protein 3 Human genes 0.000 claims description 4
- 102100031403 Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe Human genes 0.000 claims description 4
- 102100025878 C1q-related factor Human genes 0.000 claims description 4
- 102100037398 Casein kinase I isoform epsilon Human genes 0.000 claims description 4
- 102100038215 Chromodomain-helicase-DNA-binding protein 7 Human genes 0.000 claims description 4
- 102000009503 Cyclin-Dependent Kinase Inhibitor p18 Human genes 0.000 claims description 4
- 108010009367 Cyclin-Dependent Kinase Inhibitor p18 Proteins 0.000 claims description 4
- 102100033463 DENN domain-containing protein 2A Human genes 0.000 claims description 4
- 102100021045 DNA-binding protein RFX7 Human genes 0.000 claims description 4
- 102100023348 DNA-directed RNA polymerases I, II, and III subunit RPABC2 Human genes 0.000 claims description 4
- 102100035316 Doublesex- and mab-3-related transcription factor A2 Human genes 0.000 claims description 4
- 102100039798 E3 ubiquitin-protein ligase RNF180 Human genes 0.000 claims description 4
- 102100024739 E3 ubiquitin-protein ligase UHRF1 Human genes 0.000 claims description 4
- 102100039563 ETS translocation variant 1 Human genes 0.000 claims description 4
- 102100032050 Elongation of very long chain fatty acids protein 2 Human genes 0.000 claims description 4
- 102100022447 Eukaryotic translation initiation factor 4E-binding protein 2 Human genes 0.000 claims description 4
- 102100032191 Guanine nucleotide exchange factor VAV3 Human genes 0.000 claims description 4
- 102100023926 Heparan sulfate glucosamine 3-O-sulfotransferase 3B1 Human genes 0.000 claims description 4
- 101000720147 Homo sapiens Acyl-CoA synthetase short-chain family member 3, mitochondrial Proteins 0.000 claims description 4
- 101000928176 Homo sapiens Adhesion G protein-coupled receptor L3 Proteins 0.000 claims description 4
- 101000933354 Homo sapiens BMP/retinoic acid-inducible neural-specific protein 3 Proteins 0.000 claims description 4
- 101001130526 Homo sapiens Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe Proteins 0.000 claims description 4
- 101000933668 Homo sapiens C1q-related factor Proteins 0.000 claims description 4
- 101001026376 Homo sapiens Casein kinase I isoform epsilon Proteins 0.000 claims description 4
- 101000883739 Homo sapiens Chromodomain-helicase-DNA-binding protein 7 Proteins 0.000 claims description 4
- 101000870876 Homo sapiens DENN domain-containing protein 2A Proteins 0.000 claims description 4
- 101001075459 Homo sapiens DNA-binding protein RFX7 Proteins 0.000 claims description 4
- 101000686009 Homo sapiens DNA-directed RNA polymerases I, II, and III subunit RPABC2 Proteins 0.000 claims description 4
- 101000949728 Homo sapiens Doublesex- and mab-3-related transcription factor A2 Proteins 0.000 claims description 4
- 101000667651 Homo sapiens E3 ubiquitin-protein ligase RNF180 Proteins 0.000 claims description 4
- 101000760417 Homo sapiens E3 ubiquitin-protein ligase UHRF1 Proteins 0.000 claims description 4
- 101000813729 Homo sapiens ETS translocation variant 1 Proteins 0.000 claims description 4
- 101000921368 Homo sapiens Elongation of very long chain fatty acids protein 2 Proteins 0.000 claims description 4
- 101000678283 Homo sapiens Eukaryotic translation initiation factor 4E-binding protein 2 Proteins 0.000 claims description 4
- 101000775742 Homo sapiens Guanine nucleotide exchange factor VAV3 Proteins 0.000 claims description 4
- 101001048112 Homo sapiens Heparan sulfate glucosamine 3-O-sulfotransferase 3B1 Proteins 0.000 claims description 4
- 101000852852 Homo sapiens Innate immunity activator protein Proteins 0.000 claims description 4
- 101000997670 Homo sapiens Integrin beta-8 Proteins 0.000 claims description 4
- 101001005196 Homo sapiens LIX1-like protein Proteins 0.000 claims description 4
- 101001011886 Homo sapiens Matrix metalloproteinase-16 Proteins 0.000 claims description 4
- 101000687968 Homo sapiens Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase Proteins 0.000 claims description 4
- 101001109470 Homo sapiens NKG2-E type II integral membrane protein Proteins 0.000 claims description 4
- 101001007703 Homo sapiens Neurexophilin-1 Proteins 0.000 claims description 4
- 101000603239 Homo sapiens Neuroligin-1 Proteins 0.000 claims description 4
- 101001128969 Homo sapiens Neuron navigator 1 Proteins 0.000 claims description 4
- 101001111328 Homo sapiens Nuclear factor 1 A-type Proteins 0.000 claims description 4
- 101000974356 Homo sapiens Nuclear receptor coactivator 3 Proteins 0.000 claims description 4
- 101001120753 Homo sapiens Oligodendrocyte transcription factor 1 Proteins 0.000 claims description 4
- 101000572986 Homo sapiens POU domain, class 3, transcription factor 2 Proteins 0.000 claims description 4
- 101001072590 Homo sapiens POZ-, AT hook-, and zinc finger-containing protein 1 Proteins 0.000 claims description 4
- 101000582978 Homo sapiens Phospholipid phosphatase-related protein type 1 Proteins 0.000 claims description 4
- 101000613343 Homo sapiens Polycomb group RING finger protein 2 Proteins 0.000 claims description 4
- 101000596012 Homo sapiens Protein TASOR 2 Proteins 0.000 claims description 4
- 101001093143 Homo sapiens Protein transport protein Sec61 subunit gamma Proteins 0.000 claims description 4
- 101000796015 Homo sapiens Protein turtle homolog B Proteins 0.000 claims description 4
- 101001002190 Homo sapiens Putative postmeiotic segregation increased 2-like protein 11 Proteins 0.000 claims description 4
- 101000629807 Homo sapiens RNA-binding protein MEX3A Proteins 0.000 claims description 4
- 101000604114 Homo sapiens RNA-binding protein Nova-1 Proteins 0.000 claims description 4
- 101000740205 Homo sapiens Sal-like protein 1 Proteins 0.000 claims description 4
- 101000739671 Homo sapiens Semaphorin-6D Proteins 0.000 claims description 4
- 101000703741 Homo sapiens Short stature homeobox protein 2 Proteins 0.000 claims description 4
- 101000665020 Homo sapiens Sorting nexin-5 Proteins 0.000 claims description 4
- 101000716994 Homo sapiens Suppressor APC domain-containing protein 2 Proteins 0.000 claims description 4
- 101000687808 Homo sapiens Suppressor of cytokine signaling 2 Proteins 0.000 claims description 4
- 101000713234 Homo sapiens TRIO and F-actin-binding protein Proteins 0.000 claims description 4
- 101000633629 Homo sapiens Teashirt homolog 1 Proteins 0.000 claims description 4
- 101000642514 Homo sapiens Transcription factor SOX-4 Proteins 0.000 claims description 4
- 101000642517 Homo sapiens Transcription factor SOX-6 Proteins 0.000 claims description 4
- 101000642528 Homo sapiens Transcription factor SOX-8 Proteins 0.000 claims description 4
- 101000711846 Homo sapiens Transcription factor SOX-9 Proteins 0.000 claims description 4
- 101000836148 Homo sapiens Transforming acidic coiled-coil-containing protein 2 Proteins 0.000 claims description 4
- 101000663031 Homo sapiens Transmembrane and coiled-coil domains protein 1 Proteins 0.000 claims description 4
- 101000801227 Homo sapiens Tumor necrosis factor receptor superfamily member 19 Proteins 0.000 claims description 4
- 101000610557 Homo sapiens U4/U6 small nuclear ribonucleoprotein Prp31 Proteins 0.000 claims description 4
- 101000910748 Homo sapiens Voltage-dependent calcium channel gamma-4 subunit Proteins 0.000 claims description 4
- 101000785626 Homo sapiens Zinc finger E-box-binding homeobox 1 Proteins 0.000 claims description 4
- 101000723746 Homo sapiens Zinc finger protein 22 Proteins 0.000 claims description 4
- 101000782483 Homo sapiens Zinc finger protein 462 Proteins 0.000 claims description 4
- 101000802335 Homo sapiens Zinc finger protein 558 Proteins 0.000 claims description 4
- 102100036724 Innate immunity activator protein Human genes 0.000 claims description 4
- 102100033336 Integrin beta-8 Human genes 0.000 claims description 4
- 102100025850 LIX1-like protein Human genes 0.000 claims description 4
- 102100030200 Matrix metalloproteinase-16 Human genes 0.000 claims description 4
- 102100024262 Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase Human genes 0.000 claims description 4
- 108010063737 Myristoylated Alanine-Rich C Kinase Substrate Proteins 0.000 claims description 4
- 102000015695 Myristoylated Alanine-Rich C Kinase Substrate Human genes 0.000 claims description 4
- 102100022701 NKG2-E type II integral membrane protein Human genes 0.000 claims description 4
- 102100027527 Neurexophilin-1 Human genes 0.000 claims description 4
- 102100038992 Neuroligin-1 Human genes 0.000 claims description 4
- 102100031225 Neuron navigator 1 Human genes 0.000 claims description 4
- 102100024006 Nuclear factor 1 A-type Human genes 0.000 claims description 4
- 102100022883 Nuclear receptor coactivator 3 Human genes 0.000 claims description 4
- 102100026073 Oligodendrocyte transcription factor 1 Human genes 0.000 claims description 4
- 102100026459 POU domain, class 3, transcription factor 2 Human genes 0.000 claims description 4
- 102100036665 POZ-, AT hook-, and zinc finger-containing protein 1 Human genes 0.000 claims description 4
- 102100030288 Phospholipid phosphatase-related protein type 1 Human genes 0.000 claims description 4
- 102100037596 Platelet-derived growth factor subunit A Human genes 0.000 claims description 4
- 102100040919 Polycomb group RING finger protein 2 Human genes 0.000 claims description 4
- 102100035171 Protein TASOR 2 Human genes 0.000 claims description 4
- 102100036306 Protein transport protein Sec61 subunit gamma Human genes 0.000 claims description 4
- 102100031337 Protein turtle homolog B Human genes 0.000 claims description 4
- 102100020955 Putative postmeiotic segregation increased 2-like protein 11 Human genes 0.000 claims description 4
- 102100026875 RNA-binding protein MEX3A Human genes 0.000 claims description 4
- 102100038427 RNA-binding protein Nova-1 Human genes 0.000 claims description 4
- 102100037204 Sal-like protein 1 Human genes 0.000 claims description 4
- 102100037548 Semaphorin-6D Human genes 0.000 claims description 4
- 102100031976 Short stature homeobox protein 2 Human genes 0.000 claims description 4
- 102100038624 Sorting nexin-5 Human genes 0.000 claims description 4
- 102100020923 Suppressor APC domain-containing protein 2 Human genes 0.000 claims description 4
- 102100024784 Suppressor of cytokine signaling 2 Human genes 0.000 claims description 4
- 102100036855 TRIO and F-actin-binding protein Human genes 0.000 claims description 4
- 102100029223 Teashirt homolog 1 Human genes 0.000 claims description 4
- 102100036693 Transcription factor SOX-4 Human genes 0.000 claims description 4
- 102100036694 Transcription factor SOX-6 Human genes 0.000 claims description 4
- 102100036731 Transcription factor SOX-8 Human genes 0.000 claims description 4
- 102100034204 Transcription factor SOX-9 Human genes 0.000 claims description 4
- 102100027044 Transforming acidic coiled-coil-containing protein 2 Human genes 0.000 claims description 4
- 102100037718 Transmembrane and coiled-coil domains protein 1 Human genes 0.000 claims description 4
- 102100033760 Tumor necrosis factor receptor superfamily member 19 Human genes 0.000 claims description 4
- 102100040118 U4/U6 small nuclear ribonucleoprotein Prp31 Human genes 0.000 claims description 4
- 102100024143 Voltage-dependent calcium channel gamma-4 subunit Human genes 0.000 claims description 4
- 102100026457 Zinc finger E-box-binding homeobox 1 Human genes 0.000 claims description 4
- 102100028356 Zinc finger protein 22 Human genes 0.000 claims description 4
- 102100035849 Zinc finger protein 462 Human genes 0.000 claims description 4
- 102100034656 Zinc finger protein 558 Human genes 0.000 claims description 4
- 238000002966 oligonucleotide array Methods 0.000 claims description 4
- 108010017843 platelet-derived growth factor A Proteins 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 210000004498 neuroglial cell Anatomy 0.000 claims 1
- 239000003550 marker Substances 0.000 abstract description 14
- 238000003745 diagnosis Methods 0.000 abstract description 13
- 230000000877 morphologic effect Effects 0.000 abstract description 7
- 238000002474 experimental method Methods 0.000 abstract description 4
- 238000003759 clinical diagnosis Methods 0.000 abstract description 3
- 230000004069 differentiation Effects 0.000 abstract description 2
- 210000001178 neural stem cell Anatomy 0.000 abstract description 2
- 239000000523 sample Substances 0.000 description 79
- 108010029485 Protein Isoforms Proteins 0.000 description 20
- 102000001708 Protein Isoforms Human genes 0.000 description 20
- 238000000034 method Methods 0.000 description 10
- 238000012216 screening Methods 0.000 description 7
- 238000011160 research Methods 0.000 description 6
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
- 201000010133 Oligodendroglioma Diseases 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- 230000002490 cerebral effect Effects 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 206010003571 Astrocytoma Diseases 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 238000002372 labelling Methods 0.000 description 4
- 230000036210 malignancy Effects 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 238000010827 pathological analysis Methods 0.000 description 4
- 229940085606 rembrandt Drugs 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 238000007621 cluster analysis Methods 0.000 description 3
- 239000002299 complementary DNA Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000002493 microarray Methods 0.000 description 3
- 206010073131 oligoastrocytoma Diseases 0.000 description 3
- 238000003757 reverse transcription PCR Methods 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 238000012313 Kruskal-Wallis test Methods 0.000 description 2
- 238000012197 amplification kit Methods 0.000 description 2
- 230000004186 co-expression Effects 0.000 description 2
- 238000003748 differential diagnosis Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001325 log-rank test Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 101150084399 37 gene Proteins 0.000 description 1
- 108020005544 Antisense RNA Proteins 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 108010009202 Growth Factor Receptors Proteins 0.000 description 1
- 102000009465 Growth Factor Receptors Human genes 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 238000010220 Pearson correlation analysis Methods 0.000 description 1
- 230000003416 augmentation Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 208000025997 central nervous system neoplasm Diseases 0.000 description 1
- 239000003184 complementary RNA Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000007417 hierarchical cluster analysis Methods 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000000528 statistical test Methods 0.000 description 1
- 238000002626 targeted therapy Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (9)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310202569.1A CN104178556B (zh) | 2013-05-28 | 2013-05-28 | 神经胶质瘤分子分型基因群及其应用 |
US14/894,197 US20160102364A1 (en) | 2013-05-28 | 2014-05-27 | Neuroglioma Molecular Subtyping Gene Group and Use Thereof |
PCT/CN2014/000535 WO2014190760A1 (zh) | 2013-05-28 | 2014-05-27 | 神经胶质瘤分子分型基因群及其应用 |
US15/981,205 US20180258499A1 (en) | 2013-05-28 | 2018-05-16 | Neuroglioma molecular subtyping gene group and use thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310202569.1A CN104178556B (zh) | 2013-05-28 | 2013-05-28 | 神经胶质瘤分子分型基因群及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104178556A CN104178556A (zh) | 2014-12-03 |
CN104178556B true CN104178556B (zh) | 2016-08-17 |
Family
ID=51959899
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310202569.1A Expired - Fee Related CN104178556B (zh) | 2013-05-28 | 2013-05-28 | 神经胶质瘤分子分型基因群及其应用 |
Country Status (3)
Country | Link |
---|---|
US (2) | US20160102364A1 (zh) |
CN (1) | CN104178556B (zh) |
WO (1) | WO2014190760A1 (zh) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105675868A (zh) * | 2016-01-15 | 2016-06-15 | 江涛 | 基于idh1-r132h和atrx表达的胶质瘤分型*** |
CN108570501B (zh) * | 2018-04-28 | 2020-06-12 | 北京师范大学 | 多发性骨髓瘤分子分型及应用 |
CN108559778B (zh) * | 2018-04-28 | 2020-06-12 | 北京师范大学 | 多发性骨髓瘤分子分型及其在用药指导上的应用 |
CN109182527B (zh) * | 2018-10-19 | 2022-03-01 | 中国医科大学附属第一医院 | 一种用于胶质瘤中预后评价及化疗效果预测的干扰素相关试剂盒 |
CN109913549B (zh) * | 2019-03-07 | 2021-02-05 | 北京师范大学 | 基于cdc20基因共表达网络的胶质瘤分子分型及应用 |
CN109913420A (zh) * | 2019-03-07 | 2019-06-21 | 北京师范大学 | Cdc20共表达基因网络作为胶质瘤治疗靶点的应用 |
CN110468207B (zh) * | 2019-09-02 | 2021-03-23 | 北京师范大学 | 基于Taqman低密度芯片的胶质瘤EM/PM分子分型方法及其应用 |
KR102139315B1 (ko) * | 2020-02-27 | 2020-07-29 | 이화여자대학교 산학협력단 | Tnfrsf19 유전자의 dna 메틸레이션 변화를 이용한 알츠하이머병 치매 조기진단 마커 |
CN111317820B (zh) * | 2020-04-10 | 2021-06-11 | 中国药科大学 | 剪接因子prpf31抑制剂用于制备药物的用途 |
CN112215826A (zh) * | 2020-10-19 | 2021-01-12 | 天津大学 | 一种基于深度图像特征预测胶质瘤分子亚型及预后方法 |
CN112980952B (zh) * | 2021-02-05 | 2022-11-29 | 中山大学肿瘤防治中心(中山大学附属肿瘤医院、中山大学肿瘤研究所) | 用于预测异柠檬酸脱氢酶1基因野生型胶质瘤预后与抗pd1治疗疗效的标志物及其应用 |
CN114134231B (zh) * | 2021-12-07 | 2023-08-25 | 武汉瑟文生物科技有限公司 | 一种基于ecDNA的脑胶质瘤基因标志物及其应用 |
CN115216492B (zh) * | 2022-06-29 | 2023-05-30 | 浙江欧赛思生物科技有限公司 | 一种小鼠原发神经胶质瘤模型的制备方法及其应用 |
CN115064213B (zh) * | 2022-08-18 | 2022-11-01 | 神州医疗科技股份有限公司 | 基于肿瘤样本的多组学联合分析方法和*** |
CN115862876B (zh) * | 2023-03-02 | 2023-05-26 | 北京师范大学 | 基于免疫微环境基因群预测肺腺癌患者预后的装置 |
CN117594133A (zh) * | 2024-01-19 | 2024-02-23 | 普瑞基准科技(北京)有限公司 | 用于判别子宫病变类别的生物标志物的筛选方法及其应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070141066A1 (en) * | 2005-12-16 | 2007-06-21 | Genentech, Inc. | Method for Diagnosing, Prognosing and Treating Glioma |
EP2350656B1 (en) * | 2008-10-30 | 2015-01-07 | The Translational Genomics Research Institute | Methods and kits to identify invasive glioblastoma |
KR20130056855A (ko) * | 2010-03-01 | 2013-05-30 | 카리스 라이프 사이언스 룩셈부르크 홀딩스 | 치료진단용 생물학적 지표들 |
CN102041316A (zh) * | 2010-11-30 | 2011-05-04 | 华东师范大学 | miRNA-219化合物作为脑胶质瘤标志物的应用 |
-
2013
- 2013-05-28 CN CN201310202569.1A patent/CN104178556B/zh not_active Expired - Fee Related
-
2014
- 2014-05-27 WO PCT/CN2014/000535 patent/WO2014190760A1/zh active Application Filing
- 2014-05-27 US US14/894,197 patent/US20160102364A1/en not_active Abandoned
-
2018
- 2018-05-16 US US15/981,205 patent/US20180258499A1/en not_active Abandoned
Non-Patent Citations (3)
Title |
---|
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.;Verhaak RG et.al;《cancer cell》;20100131;98页摘要 * |
Simultaneous prospective purification of adult subventricular zone neural stem cells and their progeny.;Pastrana e et.al;《Proc Natl Acad Sci U S A》;20090414;6387-6392页 * |
Targeting brain cancer:advances in the molecular pathology of malignant giloma and medulloblastoma.;Huse JT et.al;《Nat rev cancer》;20100531;319-331页 * |
Also Published As
Publication number | Publication date |
---|---|
CN104178556A (zh) | 2014-12-03 |
US20180258499A1 (en) | 2018-09-13 |
US20160102364A1 (en) | 2016-04-14 |
WO2014190760A1 (zh) | 2014-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104178556B (zh) | 神经胶质瘤分子分型基因群及其应用 | |
Hu et al. | The repertoire of serous ovarian cancer non-genetic heterogeneity revealed by single-cell sequencing of normal fallopian tube epithelial cells | |
Su et al. | Single cell proteomics in biomedicine: High‐dimensional data acquisition, visualization, and analysis | |
Piccolo et al. | A single-sample microarray normalization method to facilitate personalized-medicine workflows | |
CN101942502B (zh) | 胰腺癌标记物及其检测方法、试剂盒和生物芯片 | |
Masaeli et al. | Multiparameter mechanical and morphometric screening of cells | |
Van Laar et al. | Translating a gene expression signature for multiple myeloma prognosis into a robust high-throughput assay for clinical use | |
Alizart et al. | Molecular classification of breast carcinoma | |
CN102952854A (zh) | 单细胞分类和筛选方法及其装置 | |
CN111653314B (zh) | 一种分析识别***浸润的方法 | |
Dunkler et al. | Statistical analysis principles for Omics data | |
JP2007508812A (ja) | 乳癌分類に関する材料および方法 | |
Miller et al. | Expression genomics in breast cancer research: microarrays at the crossroads of biology and medicine | |
CN112908470A (zh) | 一种基于rna结合蛋白基因的肝细胞癌预后评分***及其应用 | |
CN104419641A (zh) | 乳腺癌术前化学疗法的敏感性的判断装置及信息获取方法 | |
JP2016073287A (ja) | 腫瘍特性及びマーカーセットの同定のための方法、腫瘍分類、並びに癌のマーカーセット | |
Wang et al. | Identification of diagnostic markers for major depressive disorder by cross-validation of data from whole blood samples | |
Gruvberger-Saal et al. | Microarrays in breast cancer research and clinical practice–the future lies ahead | |
KR20080004551A (ko) | 유방암 분류에 관한 재료 및 방법 | |
US20110130302A1 (en) | Biological pathways associated with chemotherapy outcome for breast cancer | |
CN1549864A (zh) | 用于预测癌症复发的评定体系 | |
Gormley et al. | Prediction potential of candidate biomarker sets identified and validated on gene expression data from multiple datasets | |
US20130157887A1 (en) | Discrete states for use as biomarkers | |
US20100331210A1 (en) | Methods and systems for evaluating the sensitivity or resistance of tumor specimens to chemotherapeutic agents | |
Gordon | Transcriptional profiling of mesothelioma using microarrays |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160816 Address after: 213032 Changzhou New District, Jiangsu New Town Industrial Park, No. 9 Patentee after: Changzhou's Electronic Equipment Co.,Ltd. Address before: 100875 Beijing city Haidian District Xinjiekou Avenue No. 19 Patentee before: Beijing Normal University |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170116 Address after: 100176 Beijing economic and Technological Development Zone, Beijing, No. five, sea road, No. 58, building 1, floor 6 Patentee after: BEIJING JINDAI BIOTECHNOLOGY Co.,Ltd. Address before: 213032 Changzhou New District, Jiangsu New Town Industrial Park, No. 9 Patentee before: Changzhou's Electronic Equipment Co.,Ltd. |
|
CP02 | Change in the address of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: 102627 2nd Floor (02) 202, No. 1 Building, 6 Jinxing West Road, Daxing District, Beijing Patentee after: BEIJING JINDAI BIOTECHNOLOGY Co.,Ltd. Address before: 100176 Beijing economic and Technological Development Zone, Beijing, No. five, sea road, No. 58, building 1, floor 6 Patentee before: BEIJING JINDAI BIOTECHNOLOGY Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160817 |